Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Conference News ESC 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

Todd Neale

September 01, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Shelley Wood

November 01, 2021

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

Statins in COVID-19: More Signs of Potential Benefit

Todd Neale

February 26, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News ACC 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Shelley Wood

March 11, 2018

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

Advertisement

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

November 2022 News Roundup

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Elective Revascularization, Better Long-term Survival: Meta-analysis

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Statins in COVID-19: More Signs of Potential Benefit

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

New Performance and Quality Metrics for STEMI and NSTEMI Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content